ENETS Webinar and Podcast Series

Transferring research to education and teaching is a major goal at ENETS. Thanks to the involvement of ENETS education board and pharma partnerships, ENETS has implemented a programme of webinars (75 minutes) and podcasts (10 minutes) with the objective to check progress on most moving fields of NEN management. State-of-the art and unmet needs will be highlighted. We expect fruitful and numerous discussions and hope this programme will help encourage better care and research for our patients.

The webinar series is intended for HCPs qualified by law to prescribe medicine.

Please note that to watch the live webinar, you will be required to log into MY ENETS.

(The ENETS webinar series is free of charge and no registration is necessary - you do not even need to be an ENETS member! All you need is a free ENETS account. You don't yet have an ENETS account? Create one here.)

A new "NET" surprise - ENETS podcasts

The ENETS Education Group has organised small “NET” presents for the NET community in the form of 4 podcasts. Topics include:

  • Engaging and recruiting patients in clinical trials
  • I was referred a patient with a gastric neuroendocrine neoplasm (NEN) found at upper GI endoscopy (for dyspepsia). What to do next?
  • Somatostatin receptor ‘positive lesions’: how to determine the optimal cut-off for PRRT
  • Therapeutic intervention in metastatic NETs: What we should know before starting therapy

Upcoming webinars in the series

Don't miss out on any of the upcoming webinars in the ENETS webinar series. All webinars will take place from 18:00 - 19:30 CE(S)T.

ENETS-NANETS Webinar: PRRT and drug development abstracts

ENETS-NANETS Webinar: New signals, directions & signals

ENETS webinar: What has changed in the new guidance ENETS manuscript in 2023? Characterisation and treatment


ENETS Webinar: Surgical strategies for patients with MEN1

ENETS Webinar: Change in grade and differentiation: what do we learn for patient management?

ENETS Webinar: Most frequent confusions in NEN management

CME accreditation

ENETS is pleased to confirm that each webinar in the ENETS webinar series - starting with the webinar on 26 May 2021 - has been accredited  by the European Accreditation Council for Continuing Medical Education (EACCME®). (Exception: The webinar on 26 June 2024 has no UEMS accreditation.)

In order to gain CME credits for our webinars, participants are required to:

  • attend the live event and
  • submit a feedback form.

CME credits will be allocated according to the time the viewer participates in a live webinar:

30 - 59 minutes viewing time = 0.5 CME credits, 60 or more minutes viewing time = 1 CME credits.

(For viewing times under 30 minutes and for webinars watched afterwards in our webinar archive, no CME credits will be allocated.)


ENETS webinar archive

Don't worry if you missed any of the ENETS webinars - you can now view these in the ENETS webinar archive, free of charge, by clicking on the button below. ENETS has hosted numerous webinars to date in its webinar series:


  • Management of functioning syndrome in advanced NET: What can we expect? - 24 April 2024
  • Theranostics in NET: Hit and Miss - 21 February 2024
  • Diagnosis/treatment of rare, advanced NETS - 24 January 2024


  • Systemic therapy: New advances - 13 December 2023
  • Local management of bone metastases in advanced NETs: What do I expect? - 27 September 2023
  • SPECIAL EDITION: CHD Task Force Webinar - Synoptic reporting of echocardiography in Carcinoid Heart Disease - 27 July 2023
  • How to interpret imaging results in NETs: Being aware of false positive and false negative results - 28 June 2023
  • Genetic syndromes in NEN: What is new? - 19 April 2023
  • Best Supportive Care: The Holistic Approach to a NET patient - 22 February 2023
  • Immunotherapy: Where do we stand in NET, NEC, Pheochromocytomas and Paragangliomas (PPGL), Medullary Thyroid Carcinomas (MTC) and Merkel cell carcinomas (MCC)? - 25 January 2023


  • Endoscopic treatment options in localised digestive NET – When and how? - 14 December 2022
  • Functioning Syndromes in NENs – From patient journey to clinical dos and don’ts: Quantifying the severity of symptoms and preventing common mistakes - 16 November 2022
  • Appraisal of locoregional treatments in NET - 26 October 2022
  • Update in the diagnosis and characterisation of NEN- 28 September 2022
  • Selection of the most appropriate chemotherapy, type and precise modality of administration in metastatic GEP-NENs - 20 July 2022
  • Role of molecular testing for individualising therapy in GEP and thoracic NENs - 29 June 2022
  • Side effects/toxicity of commonly used agents: Identify risk of cumulative side effects - 25 May 2022
  • Best treatment sequences in advanced NET? - 27 April 2022
  • Does surgery cure localized NET? Which level of evidence? - 30 March 2022
  • ABC in NEN - 26 January 2022
  • Surgery of localised digestive NET - a tailored approach - 12 January 2022


  • "Post-OMICS" landscape and agnostic strategy - 24 November 2021
  • PRRT – practical issues & "grey areas" - 27 October 2021
  • Neoadjuvant and adjuvant NET therapy: Is it an option? - 29 September 2021
  • New TKI results in NETs - 21 July 2021
  • Advanced NET treatments: what have we learned and what do we expect? - 30 June 2021
  • Neuroendocrine carcinomas (NECs): diagnostic and therapeutic - 26 May 2021
  • Choosing the best treatment sequence for NET - 28 April 2021
  • NEN guidelines - implementation in daily practice and unmet needs - 31 March 2021
  • ABC in NEN - 27 January 2021


  • Highlights from ESMO 2020 - 5 November 2020
  • An update on SSA including combination and maintenance therapy - 8 October 2020
  • Covid-19 disease and its impact on NET therapy (incl. chemotherapy and targeted drugs) - 11 June 2020
  • Covid-19 disease and its impact on NET therapy (incl. somatostatin receptor targeted therapies) - 11 June 2020